Celiac Research Partnership Builds Takeda’s GI Interests
This article was originally published in PharmAsia News
Executive Summary
Takeda continues to expand its interests in the gastrointestinal area through a joint research and development agreement with a small US venture for novel nanoparticle immune modulating therapies for celiac disease.